317 related articles for article (PubMed ID: 19720797)
1. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
De Cosmo S; Motterlini N; Prudente S; Pellegrini F; Trevisan R; Bossi A; Remuzzi G; Trischitta V; Ruggenenti P;
Diabetes; 2009 Dec; 58(12):2920-9. PubMed ID: 19720797
[TBL] [Abstract][Full Text] [Related]
2. Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy.
Chen YN; Wang PW; Tung SC; Kuo MC; Weng SW; Chou CK; Chang CM; Tsa CJ; Taso CF; Shen FC; Chen JF
J Diabetes Investig; 2020 Jul; 11(4):923-929. PubMed ID: 31912623
[TBL] [Abstract][Full Text] [Related]
3. Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
Stefański A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Moleda P; Pilarska K
J Hum Hypertens; 2006 Sep; 20(9):684-92. PubMed ID: 16625233
[TBL] [Abstract][Full Text] [Related]
4. The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.
Lapice E; Monticelli A; Cocozza S; Pinelli M; Cocozza S; Bruzzese D; Riccardi G; Vaccaro O
J Transl Med; 2015 Mar; 13():85. PubMed ID: 25889595
[TBL] [Abstract][Full Text] [Related]
5. Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).
Ruggenenti P; Iliev I; Costa GM; Parvanova A; Perna A; Giuliano GA; Motterlini N; Ene-Iordache B; Remuzzi G;
Diabetes Care; 2008 Aug; 31(8):1629-34. PubMed ID: 18443191
[TBL] [Abstract][Full Text] [Related]
6. The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics.
BENEDICT Group
Control Clin Trials; 2003 Aug; 24(4):442-61. PubMed ID: 12865039
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
[TBL] [Abstract][Full Text] [Related]
8. PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
Jermendy A; Körner A; Kovács M; Madácsy L; Cseh K
J Pediatr Endocrinol Metab; 2011; 24(1-2):55-9. PubMed ID: 21528816
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
Herrmann SM; Ringel J; Wang JG; Staessen JA; Brand E;
Diabetes; 2002 Aug; 51(8):2653-7. PubMed ID: 12145184
[TBL] [Abstract][Full Text] [Related]
10. Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients.
Vaccaro O; Lapice E; Monticelli A; Giacchetti M; Castaldo I; Galasso R; Pinelli M; Donnarumma G; Rivellese AA; Cocozza S; Riccardi G
Diabetes Care; 2007 May; 30(5):1156-61. PubMed ID: 17259473
[TBL] [Abstract][Full Text] [Related]
11. Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial.
Ruggenenti P; Fassi A; Ilieva A; Iliev IP; Chiurchiu C; Rubis N; Gherardi G; Ene-Iordache B; Gaspari F; Perna A; Cravedi P; Bossi A; Trevisan R; Motterlini N; Remuzzi G;
J Hypertens; 2011 Feb; 29(2):207-16. PubMed ID: 21243736
[TBL] [Abstract][Full Text] [Related]
12. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.
Lee BC; Lee HJ; Chung JH
Neurosci Lett; 2006 Dec; 410(2):141-5. PubMed ID: 17084528
[TBL] [Abstract][Full Text] [Related]
14. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
[TBL] [Abstract][Full Text] [Related]
16. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
Caramori ML; Canani LH; Costa LA; Gross JL
Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
[TBL] [Abstract][Full Text] [Related]
17. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.
Liu L; Zheng T; Wang F; Wang N; Song Y; Li M; Li L; Jiang J; Zhao W
Diabetes Care; 2010 Jan; 33(1):144-9. PubMed ID: 19837787
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.
Zhang H; Zhu S; Chen J; Tang Y; Hu H; Mohan V; Venkatesan R; Wang J; Chen H
Diabetes Care; 2012 Jun; 35(6):1388-93. PubMed ID: 22619290
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
Azab MM; Abdel-Azeez HA; Zanaty MF; El Alawi SM
Clin Lab; 2014; 60(5):743-9. PubMed ID: 24839816
[TBL] [Abstract][Full Text] [Related]
20. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
